一个双响应的纳米水凝系统,用于持续的药物输送和软骨透,用于骨关节炎治疗
Kai Zhou1, Xinlong He2, Kun Shi2
1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, China; Department of Orthopedics and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
概括
这项研究引入了一种用于骨关节炎治疗的新型纳米水凝,改善药物输送和软骨中的保留. 该系统通过向干细胞和克服输送障碍来增强软骨修复.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 药物输送系统 药物输送系统
背景情况:
- 骨关节炎 (OA) 涉及到软骨的分解,由于矩阵障碍,阻碍了自我修复.
- 目前的药物输送方法与软骨透和长时间的保留斗争.
- 向骨髓介质干细胞 (BMSCs) 对于软骨再生至关重要.
研究的目的:
- 开发一种双生理信号响应纳米水凝 (KPP@PLEL),用于增强OA治疗.
- 为了改善药物输送,软骨透和卡尔托根因 (KGN) 的保留.
- 为了利用热敏度和MMP-13酶的响应性,针对向的KGN释放.
主要方法:
- 在热敏水凝 (PLEL) 中封装KGN的KPP@PLEL纳米水凝的制造.
- 修改聚胺胺 (PAMAM) 树突与MMP-13响应性.
- 在体外和体内对生物相容性,软骨透,保留和治疗功效的评估.
主要成果:
- KPP@PLEL显示出优异的生物相容性和减少炎症.
- 增强KGN向深软骨基质的传递,持续释放和长时间的关节保留.
- 在体内显著的软骨再生和减少骨关节炎的进展.
- 促进了BMSC分化成冠状细胞.
结论:
- KPP@PLEL纳米水凝为OA治疗提供了一个有前途的平台.
- 双响应机制克服了软骨透性和保留挑战.
- 有效的药物输送和加强骨关节炎治疗的再生效果.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...


